Cambrian BioPharma Inc, 10% Owner at Sensei Biotherapeutics, Inc. (SNSE), bought 30,892 shares at $5.18 ($160K) on 2022-01-11, disclosed to the SEC on 2022-01-13.
Open-market purchase of $160k SNSE by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.18 | 10,845 | $56K | 35.0% |
| 2 | $5.18 | 10,845 | $56K | 35.0% |
| 3 | $5.22 | 9,202 | $48K | 29.9% |
| Total | $5.19 avg | 30,892 | $160K | 100% |
| Filing → |
| SNSE | SELL | 2025-12-08 | $398K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $136K | — | Filing → |
| SNSE | BUY | 2022-04-21 | $15K | — | Filing → |